Abstract
There is little information on the prevalence of hepatitis C virus (HCV) infection in China. The prevalence of HCV infection was determined in 998 subjects (398 with liver disease and 600 without) in the city of Nanjing in southern China. Subjects were tested for anti-HCV antibodies by a second generation assay. We also determined serological HCV genotypes and HCV RNA sequences. Among the 600 subjects without liver disease, 3 (0.5%) were seroreactive for anti-HCV. All were less than 12 years of age and had a history of transfusion. Of the 398 liver disease patients, 20 (5.0%) were seroreactive for anti-HCV. Of 16 patients in whom serological HCV genotype was determined, 10 (62.5%) were infected with HCV type 1, 5 (31.3%) with type 2 and 1 (6.3%) undetermined. HCV genomes sequenced from 2 patients belonged to genotype 2 and were closely related to strains in Beijing and Japan by molecular evolutionary analysis. These results suggest that HCV infection is rare and not a major cause of liver disease in southern China.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
WHO WPRO 1982: Report of scientific group on viral hepatitis and its related liver diseases.
Lee S, McHutchinson J, Francis B, et al. Improved detection of antibodies to hepatitis C virus using a second generation ELISA. Advan Exper Med Biol 1992; 312: 183–189.
T-Kohara K, Yamaguchi K, Maki N, et al. Antigenicities of group I and II hepatitis C virus polypeptides — Molecular basis of diagnosis. Virology 1993; 192: 430–437.
Tanaka T, T-Kohara K, Yamaguchi K, et al. Significance of specific antibody assay for genotyping of hepatitis C virus. Hepatology 1994; 19: 1347–1353.
Simmonds P, Alberti A, Alter HJ, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19: 1331–1334.
Okamoto H, Okada S, Sugiyama Y, et al. The 5′-terminal sequence of the hepatitis C virus genome. Jap J Exp Med 1990; 60: 167–177.
Gojobori T, Ishii K, Nei M. Estimation of average number of nucleotide substitutions when the rate of substitution varies with nucleotide. J Mol Evol 1982; 28: 163–169.
Nei M, Gojobori T. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol 1986; 3: 418–426.
Saitou N, Nei M. The neighbor joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 1987; 4: 406–425.
Tao QM, Wang Y, Wang H, et al. Seroepidemiology of HCV and HBV infection in northern China. Gastoenterol Jap 1991; 26(Suppl 3): 156–158.
Chen PJ, Lin MH, Tai KF, et al. The Taiwansese hepatitis C virus genome: Sequence determination and mapping of the 5′ termini of viral genomic and antigenomic RNA Virology 1992; 188: 102–113.
Choo QL, Richman K, Han JH, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 1991; 88: 2451–2455.
Honda M, Kaneko S, Unoura M, et al. Sequence analysis of putative structural regions of hepatitis C virus isolated from 5 Japanese patients with hepatocellular carcinoma. Arch Viol 1993; 128: 163–169.
Inchauspe G, Zebedee SL, Lee D-HH, et al. Genomic structure of the human prototype strain H of hepatitis C virus: Comparison with American and Japanese isolates. Proc Natl Acad Sci USA 1991; 88: 10292–10296.
Kato N, Hijikata M, Ootsuyama Y, et al. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA 1990; 87: 9524–9528.
Okamoto H, Okada S, Sugiyama Y, et al. Nucleotide sequences of the genomic RNA of hepatitis C virus isolated from a human carrier: Comparison with reported isolates for conserved and divergent regions. J Gen Virol 1991; 72: 2697–2704.
Okamoto H, Kurai K, Okada S-I, et al. Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: Comparative study for four distinct genotypes. Virology 1992; 188: 331–341.
Takamizawa A, Mori C, Manabe S, et al. The structure and organization of the Hepatitis C virus genome isolated from human carriers. J Virol 1991; 65: 1105–1113.
Takeuchi K, Kubo Y, Boonmar S, et al. Nucleotide sequence of core and envelope genes of the hepatitis C virus genome derived directly from human healthy carriers. Nucleric Acids Res 1990; 18: 4626–4626.
Ogata N, Alter HJ, Miller RH, et al. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci USA 1991; 88: 3392–3396.
Tanaka T, Kato N, Nakagawa M, et al. Molecular cloning of hepatitis C virus genome from a single Japanese carrier: Sequence variation within the same individual and among infected individuals. Virus Res 1992; 23: 39–53.
Xing Li, Hayashi N, Katayama K, et al. Low prevalence of hepatitis C virus antibodies in chronic disease in northwest China. J Med Virol 1993; 431: 247–250.
Lee SD, Chan CY, Wang YJ, et al. Seroepidemiology of hepatitis C virus infection in Taiwan. Hepatology 1991; 13: 830–833.
Lee SD, Wang YJ, Lin HC, et al. Prevalence of anti-HCV among Chinese patients with acute and chronic liver disease. Gastroent Hepat 1992; 7: 113–116.
Wu R-R, Mizokami M, Lau JYN, et al. Sero-prevalence of hepatitis C virus infection and its genotype in Lanzhou, western China. J Med Virol 1995; 45: 174–178.
Wang Y, Okamoto H, Mishiro S. HCV gentoypes in China. Lancet 1992; 399: 1168.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Suzuki, K., Mizokami, M., Cao, K. et al. Prevalence of hepatitis C virus infection in Nanjing, Southern China. Eur J Epidemiol 13, 511–515 (1997). https://doi.org/10.1023/A:1007320118967
Issue Date:
DOI: https://doi.org/10.1023/A:1007320118967